Skip to main contentSkip to main content
Updating results


  • Updated

Hospitals are facing mixed reviews regarding their efforts to comply with a federal requirement that they post information about prices related to nearly every health care service they provide.

  • Updated

THURSDAY, March 23, 2023 (HealthDay News) -- The prevalence of autism spectrum disorder (ASD) per 1,000 children aged 8 years was 27.6 in 2020, and prevalence was higher for boys than girls, according to research published in the March 24 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.

There are some pretty good uses for an old cellphone, if it is not too beat-up or broken. Here are five things you can do with your old phone, and none of them require an active SIM card.

China is accusing the United States of spreading disinformation and suppressing TikTok following reports that the Biden administration was calling for its Chinese owners to sell their stakes in the popular video-sharing app.

  • Updated

WEDNESDAY, March 15, 2023 (HealthDay News) -- Patients younger than 65 years undergoing total hip arthroplasty (THA) have 99 percent implant survivorship at eight years and have low rates of revision and readmission, according to a study presented at the annual meeting of the American Academy of Orthopaedic Surgeons, held from March 7 to 11 in Las Vegas.

  • Updated

TUESDAY, March 14, 2023 (HealthDay News) -- For older adults, yoga seems beneficial for markers of frailty compared with education or inactive control, according to a systematic review published online March 13 in the Annals of Internal Medicine.

U.S. government bans on Chinese-owned video sharing app TikTok reveal Washington's own insecurities and are an abuse of state power, a Chinese Foreign Ministry spokesperson said Tuesday.

  • Updated

TUESDAY, Feb. 28, 2023 (HealthDay News) -- Most U.S. adults with type 2 diabetes (T2D) meet recommended criteria for use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and sodium-glucose cotransporter-2 inhibitors (SGLT2is), but fewer than 10 percent use either of them, according to a research letter published online Feb. 28 in the Annals of Internal Medicine.

Get up-to-the-minute news sent straight to your device.


News Alerts

Breaking News